This company has been marked as potentially delisted and may not be actively trading. Neuralstem (CUR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock CUR vs. CELZ, KLTO, FRTX, TTNP, EVAX, APTO, CERO, PALI, ONVO, and GENEShould you be buying Neuralstem stock or one of its competitors? The main competitors of Neuralstem include Creative Medical Technology (CELZ), Klotho Neurosciences (KLTO), Fresh Tracks Therapeutics (FRTX), Titan Pharmaceuticals (TTNP), Evaxion Biotech A/S (EVAX), Aptose Biosciences (APTO), CERo Therapeutics (CERO), Palisade Bio (PALI), Organovo (ONVO), and Genetic Technologies (GENE). These companies are all part of the "medical" sector. Neuralstem vs. Its Competitors Creative Medical Technology Klotho Neurosciences Fresh Tracks Therapeutics Titan Pharmaceuticals Evaxion Biotech A/S Aptose Biosciences CERo Therapeutics Palisade Bio Organovo Genetic Technologies Creative Medical Technology (NASDAQ:CELZ) and Neuralstem (NASDAQ:CUR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Does the media prefer CELZ or CUR? In the previous week, Creative Medical Technology had 6 more articles in the media than Neuralstem. MarketBeat recorded 6 mentions for Creative Medical Technology and 0 mentions for Neuralstem. Neuralstem's average media sentiment score of 0.00 beat Creative Medical Technology's score of -0.35 indicating that Neuralstem is being referred to more favorably in the news media. Company Overall Sentiment Creative Medical Technology Neutral Neuralstem Neutral Does the MarketBeat Community believe in CELZ or CUR? Neuralstem received 207 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.27% of users gave Creative Medical Technology an outperform vote while only 66.83% of users gave Neuralstem an outperform vote. CompanyUnderperformOutperformCreative Medical TechnologyOutperform Votes7168.27% Underperform Votes3331.73% NeuralstemOutperform Votes27866.83% Underperform Votes13833.17% Which has stronger earnings and valuation, CELZ or CUR? Neuralstem has higher revenue and earnings than Creative Medical Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$14K406.37-$5.29M-$3.81-0.58Neuralstem$260K5.29-$4.93MN/AN/A Is CELZ or CUR more profitable? Creative Medical Technology has a net margin of 0.00% compared to Neuralstem's net margin of -39,417.64%. Creative Medical Technology's return on equity of -63.05% beat Neuralstem's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -63.05% -60.42% Neuralstem -39,417.64%-170.51%-110.16% Which has more volatility & risk, CELZ or CUR? Creative Medical Technology has a beta of 1.98, meaning that its stock price is 98% more volatile than the S&P 500. Comparatively, Neuralstem has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CELZ or CUR? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 38.3% of Neuralstem shares are held by institutional investors. 2.8% of Creative Medical Technology shares are held by company insiders. Comparatively, 5.4% of Neuralstem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryCreative Medical Technology beats Neuralstem on 7 of the 13 factors compared between the two stocks. Get Neuralstem News Delivered to You Automatically Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUR vs. The Competition Export to ExcelMetricNeuralstemBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.38M$3.12B$5.61B$8.62BDividend YieldN/A1.56%5.28%4.17%P/E RatioN/A32.9027.1419.96Price / Sales5.29466.20411.83157.63Price / CashN/A168.6838.2534.64Price / Book0.103.427.064.69Net Income-$4.93M-$72.35M$3.23B$248.14M Neuralstem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CURNeuralstemN/A$0.66-2.3%N/A-85.1%$1.38M$260K0.006Gap DownCELZCreative Medical Technology0.4461 of 5 stars$2.29+4.6%N/A-48.2%$5.92M$14K-0.605Positive NewsShort Interest ↑Analyst RevisionHigh Trading VolumeKLTOKlotho NeurosciencesN/A$0.17-0.4%N/AN/A$5.66MN/A-0.48N/AGap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A-5.0%$5.59M$10.06M-0.6620TTNPTitan Pharmaceuticals1.1931 of 5 stars$4.77-2.3%N/A-30.1%$4.36M$180K-1.0410Positive NewsShort Interest ↓Gap DownHigh Trading VolumeEVAXEvaxion Biotech A/S2.0143 of 5 stars$2.74+0.7%$10.00+265.0%-82.0%$3.84M$3.29M-1.8960Short Interest ↑APTOAptose Biosciences1.0315 of 5 starsN/A$6.00+∞N/A$3.66MN/A-0.5831Gap DownHigh Trading VolumeCEROCERo Therapeutics3.2104 of 5 stars$0.47+5.0%$7.00+1,392.5%-99.5%$3.62MN/A0.008News CoverageStock SplitPALIPalisade Bio2.4001 of 5 stars$0.74-3.2%$12.00+1,530.4%-85.4%$3.53M$250K-0.0510Short Interest ↑Gap DownONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050News CoverageHigh Trading Volume Related Companies and Tools Related Companies CELZ Alternatives KLTO Alternatives FRTX Alternatives TTNP Alternatives EVAX Alternatives APTO Alternatives CERO Alternatives PALI Alternatives ONVO Alternatives GENE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CUR) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuralstem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuralstem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CUR Stock Free CUR Stock Alerts